AMA recognizes the following companies as the key players who are driving Molecular Radiotherapy Dosimetry market, some of them are MIM Software Inc. (United States), DOSIsoft SA (France), Novartis International AG (Switzerland), Mirada Medical Ltd (United Kingdom), Ashland (United States), Sirtex Medical (Australia), mirada medical ltd (United Kingdom) and Elekta (Sweden).
According to the report, some of the important driving forces behind the market growth are Increasing Number of Breast Cancer and Prostate Cancer Patients. The primary concern of any business is the reduction of the overall operating cost. The increased need for operating efficiency and meeting regulatory demands at the same time have become major challenges for the original Players, additional restraints impacting market are Due To High Absorbed Dose Kills Normal Tissues which is continuously seeking attention of Industry Experts and Decision makers.
The study was conducted using primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market study and vendor landscape in addition to a SWOT analysis of the key Players.